[1]
2025. Histopathological Evaluation of Erythropoietin’s Protective Effect Against Doxorubicin-Induced Hepatotoxicity. Al Mustansiriyah Journal of Pharmaceutical Sciences. 25, 2 (May 2025), 192–202. DOI:https://doi.org/10.32947/ajps.v25i2.1150.